ABSTRACT
Systemic toxicity and tumor cell resistance still limit the efficacy of chemotherapy in colorectal cancer. Therefore, alternative treatments are desperately needed. The thiazolide Nitazoxanide (NTZ) is an FDA-approved drug for the treatment of parasite-mediated infectious diarrhea with a favorable safety profile. Interestingly, NTZ and the thiazolide RM4819-its bromo-derivative lacking antibiotic activity-are also promising candidates for cancer treatment. Yet the exact anticancer mechanism(s) of these compounds still remains unclear. In this study, we systematically investigated RM4819 and NTZ in 2D and 3D colorectal cancer culture systems. Both compounds strongly inhibited proliferation of colon carcinoma cell lines by promoting G1 phase cell cycle arrest. Thiazolide-induced cell cycle arrest was independent of the p53/p21 axis, but was mediated by inhibition of protein translation via the mTOR/c-Myc/p27 pathway, likely caused by inhibition of mitochondrial respiration. While both thiazolides demonstrated mitochondrial uncoupling activity, only RM4819 inhibited the mitochondrial respiratory chain complex III. Interestingly, thiazolides also potently inhibited the growth of murine colonic tumoroids in a comparable manner with cisplatin, while in contrast to cisplatin thiazolides did not affect the growth of primary intestinal organoids. Thus, thiazolides appear to have a tumor-selective antiproliferative activity, which offers new perspectives in the treatment of colorectal cancer.
Subject(s)
Colorectal Neoplasms/genetics , Electron Transport/genetics , G1 Phase Cell Cycle Checkpoints/genetics , Mitochondrial Membranes/metabolism , Thiazoles/therapeutic use , Animals , Humans , Mice , Thiazoles/chemistryABSTRACT
People punish transgressors with different intensity depending if they are members of their group or not. We explore this in a cross-sectional analytical study with paired samples in children with developmental disorders who watched two videos and expressed their opinion. In Video-1, a football-player from the participant's country scores a goal with his hand. In Video-2, a player from another country does the same against the country of the participant. Each subject watched the two videos and their answers were compared. The autism spectrum disorder (ASD) group showed negative feelings in Video 1 (M = - .1; CI 95% - .51 to .31); and in Video 2 (M = - .43; CI 95% .77 to - .09; t(8) = 1.64, p = .13), but the attention deficit hyperactivity disorder, learning disabilities, intellectual disability groups showed positive opinion in Video-1 and negative in Video-2. This suggests that children with ASD respect rules regardless of whether those who break them belong or not to their own group, possibly due to lower degrees of empathy.
Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Autism Spectrum Disorder/psychology , Emotions , Intellectual Disability/psychology , Learning Disabilities/psychology , Adolescent , Child , Cross-Sectional Studies , Ethnicity/psychology , Female , Humans , Male , Photic Stimulation , Video RecordingABSTRACT
Complexes of the type [Cp*Ir(N,N')Cl]+ (N,N' = 2-(2-dialkylaminopyrimidin-4-yl)pyrimidine) can undergo roll-over cyclometallation leading to a novel N,N'-donor site. Following this strategy heterobimetallic complexes including iridium(iii) and a Group X metal centre in the oxidation state +II were achieved.
ABSTRACT
The oncogene DJ-1 has been originally identified as a suppressor of PTEN. Further on, loss-of-function mutations have been described as a causative factor in Parkinson's disease (PD). DJ-1 has an important function in cellular antioxidant responses, but its role in central metabolism of neurons is still elusive. We applied stable isotope assisted metabolic profiling to investigate the effect of a functional loss of DJ-1 and show that DJ-1 deficient neuronal cells exhibit decreased glutamine influx and reduced serine biosynthesis. By providing precursors for GSH synthesis, these two metabolic pathways are important contributors to cellular antioxidant response. Down-regulation of these pathways, as a result of loss of DJ-1 leads to an impaired antioxidant response. Furthermore, DJ-1 deficient mouse microglia showed a weak but constitutive pro-inflammatory activation. The combined effects of altered central metabolism and constitutive activation of glia cells raise the susceptibility of dopaminergic neurons towards degeneration in patients harboring mutated DJ-1. Our work reveals metabolic alterations leading to increased cellular instability and identifies potential new intervention points that can further be studied in the light of novel translational medicine approaches.
Subject(s)
Antioxidants/metabolism , Glutamine/metabolism , Neurons/metabolism , Protein Deglycase DJ-1/metabolism , Serine/metabolism , Animals , Cells, Cultured , Humans , Metabolome , Mice , Microglia/metabolism , Mitochondria/metabolism , Oxidative Stress , Protein Deglycase DJ-1/geneticsABSTRACT
Several shortcomings of current Parkinson's disease (PD) models limit progress in identification of environmental contributions to disease pathogenesis. The conditionally immortalized cell line LUHMES promises to make human dopaminergic neuronal cultures more easily available, but these cells are difficult to culture for extended periods of time. We overcame this problem by culturing them in 3D with minor medium modifications. The 3D neuronal aggregates allowed penetration by small molecules and sufficient oxygen and nutrient supply for survival of the innermost cells. Using confocal microscopy, gene expression, and flow cytometry, we characterized the 3D model and observed a highly reproducible differentiation process. Visualization and quantification of neurites in aggregates was achieved by adding 2 % red fluorescent protein-transfected LUHMES cells. The mitochondrial toxicants and established experimental PD agents, rotenone and MPP+, perturbed genes involved in one-carbon metabolism and transsulfuration pathways (ASS1, CTH, and SHTM2) as in 2D cultures. We showed, for the first time in LUHMES, down-regulation of mir-7, a miRNA known to target alpha-synuclein and to be involved in PD. This was observed as early as 12 h after rotenone exposure, when pro-apoptotic mir-16 and rotenone-sensitive mir-210 were not yet significantly perturbed. Finally, washout experiments demonstrated that withdrawal of rotenone led to counter-regulation of mir-7 and ASS1, CTH, and SHTM2 genes. This suggests a possible role of these genes in direct cellular response to the toxicant, and the model appears to be suitable to address the processes of resilience and recovery in neurotoxicology and Parkinson's disease in future studies.
Subject(s)
Antiparkinson Agents/pharmacology , Dopaminergic Neurons/drug effects , Drug Evaluation, Preclinical/methods , Neuroprotective Agents/pharmacology , Neurotoxins/toxicity , Toxicity Tests, Acute/methods , Toxicity Tests, Chronic/methods , Cell Aggregation , Cell Culture Techniques , Cell Differentiation , Cell Line, Transformed , Cell Survival/drug effects , Dopaminergic Neurons/cytology , Dopaminergic Neurons/metabolism , Drug Resistance , Gene Expression Regulation/drug effects , Humans , Imaging, Three-Dimensional , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurites/drug effects , Neurites/metabolism , Recombinant Proteins/metabolismABSTRACT
Human embryonic stem cells (hESCs) may be applied to develop human-relevant sensitive in vitro test systems for monitoring developmental toxicants. The aim of this study was to identify potential developmental toxicity mechanisms of the histone deacetylase inhibitors (HDAC) valproic acid (VPA), suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA) relevant to the in vivo condition using a hESC model in combination with specific differentiation protocols and genome-wide gene expression and microRNA profiling. Analysis of the gene expression data showed that VPA repressed neural tube and dorsal forebrain (OTX2, ISL1, EMX2 and SOX10)-related transcripts. In addition, VPA upregulates axonogenesis and ventral forebrain-associated genes, such as SLIT1, SEMA3A, DLX2/4 and GAD2. HDACi-induced expression of miR-378 and knockdown of miR-378 increases the expression of OTX2 and EMX2, which supports our hypothesis that HDACi targets forebrain markers through miR-378. In conclusion, multilineage differentiation in vitro test system is very sensitive for monitoring molecular activities relevant to in vivo neuronal developmental toxicity. Moreover, miR-378 seems to repress the expression of the OTX2 and EMX2 and therefore could be a regulator of the development of neural tube and dorsal forebrain neurons.
Subject(s)
Histone Deacetylase Inhibitors/toxicity , Human Embryonic Stem Cells/drug effects , Human Embryonic Stem Cells/physiology , MicroRNAs/metabolism , Neurogenesis/drug effects , Neurons/drug effects , Cell Differentiation/drug effects , Genome-Wide Association Study , Human Embryonic Stem Cells/enzymology , Humans , MicroRNAs/genetics , Neurogenesis/genetics , Neurons/enzymology , Neurons/physiology , Toxicity Tests/methodsABSTRACT
Assessment of the network of toxicity pathways by Omics technologies and bioinformatic data processing paves the road toward a new toxicology for the twenty-first century. Especially, the upstream network of responses, taking place in toxicant-treated cells before a point of no return is reached, is still little explored. We studied the effects of the model neurotoxicant 1-methyl-4-phenylpyridinium (MPP(+)) by a combined metabolomics (mass spectrometry) and transcriptomics (microarrays and deep sequencing) approach to provide unbiased data on earliest cellular adaptations to stress. Neural precursor cells (LUHMES) were differentiated to homogeneous cultures of fully postmitotic human dopaminergic neurons, and then exposed to the mitochondrial respiratory chain inhibitor MPP(+) (5 µM). At 18-24 h after treatment, intracellular ATP and mitochondrial integrity were still close to control levels, but pronounced transcriptome and metabolome changes were seen. Data on altered glucose flux, depletion of phosphocreatine and oxidative stress (e.g., methionine sulfoxide formation) confirmed the validity of the approach. New findings were related to nuclear paraspeckle depletion, as well as an early activation of branches of the transsulfuration pathway to increase glutathione. Bioinformatic analysis of our data identified the transcription factor ATF-4 as an upstream regulator of early responses. Findings on this signaling pathway and on adaptive increases of glutathione production were confirmed biochemically. Metabolic and transcriptional profiling contributed complementary information on multiple primary and secondary changes that contribute to the cellular response to MPP(+). Thus, combined 'Omics' analysis is a new unbiased approach to unravel earliest metabolic changes, whose balance decides on the final cell fate.
Subject(s)
1-Methyl-4-phenylpyridinium/toxicity , Dopaminergic Neurons/drug effects , Energy Metabolism/drug effects , Mitochondria/drug effects , Neural Stem Cells/drug effects , Neurotoxicity Syndromes/etiology , Transcription, Genetic/drug effects , Activating Transcription Factor 4/genetics , Activating Transcription Factor 4/metabolism , Adaptation, Physiological , Adenosine Triphosphate/metabolism , Cell Line , Computational Biology , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Gene Expression Profiling/methods , Gene Expression Regulation , Glucose/metabolism , Glutathione/metabolism , High-Throughput Nucleotide Sequencing , Humans , Mass Spectrometry , Metabolomics/methods , Mitochondria/metabolism , Mitochondria/pathology , Neural Stem Cells/metabolism , Neural Stem Cells/pathology , Neurotoxicity Syndromes/genetics , Neurotoxicity Syndromes/metabolism , Neurotoxicity Syndromes/pathology , Oligonucleotide Array Sequence Analysis , Oxidative Stress/drug effects , Oxidative Stress/genetics , Phosphocreatine/metabolism , RNA Interference , Time Factors , TransfectionABSTRACT
Intestinal epithelial cells (IECs) not only have a critical function in the absorption of nutrients, but also act as a physical barrier between our body and the outside world. Damage and death of the epithelial cells lead to the breakdown of this barrier function and inflammation due to access of the immune system to compounds of the intestinal flora. Intestinal epithelial damage is frequently associated with various inflammatory disorders, chemo- and radiotherapy as well as drug-mediated toxicity. Until recently, intestinal epithelial-damaging activities of drugs and treatments could be tested only in vivo in animal models because of the poor survival rate of primary IECs ex vivo. The three-dimensional culture and outgrowth of intestinal crypt stem cells into organoids have offered new possibilities to culture and study IECs ex vivo. Here we demonstrate that intestinal organoids are a useful and physiologically relevant model system to study cell death and survival in IECs. We further describe a number of microscopy-based as well as colorimetric methods to monitor and score survival and death of intestinal organoids. Finally, the comparison of organoids isolated from gene-deficient mice and wild-type mice allows investigating the role of specific genes in the regulation of IEC death. Owing to their comparable structure and behavior, intestinal organoids may serve as an interesting and physiologically relevant surrogate system for large- and mid-scale in vitro testing of intestinal epithelium-damaging drugs and toxins, and for the investigation of cell death pathways.
Subject(s)
Apoptosis , Epithelial Cells/pathology , Intestinal Diseases/pathology , Intestinal Mucosa/pathology , Intestine, Small/pathology , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/deficiency , Apoptosis Regulatory Proteins/genetics , Bcl-2-Like Protein 11 , Biological Assay , Caco-2 Cells , Camptothecin/analogs & derivatives , Camptothecin/toxicity , Cisplatin/toxicity , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Humans , Intestinal Diseases/genetics , Intestinal Diseases/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestine, Small/drug effects , Intestine, Small/metabolism , Irinotecan , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Organoids , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Time Factors , Tumor Necrosis Factor-alpha/toxicityABSTRACT
Developmental toxicity in vitro assays have hitherto been established as stand-alone systems, based on a limited number of toxicants. Within the embryonic stem cell-based novel alternative tests project, we developed a test battery framework that allows inclusion of any developmental toxicity assay and that explores the responses of such test systems to a wide range of drug-like compounds. We selected 28 compounds, including several biologics (e.g., erythropoietin), classical pharmaceuticals (e.g., roflumilast) and also six environmental toxicants. The chemical, toxicological and clinical data of this screen library were compiled. In order to determine a non-cytotoxic concentration range, cytotoxicity data were obtained for all compounds from HEK293 cells and from murine embryonic stem cells. Moreover, an estimate of relevant exposures was provided by literature data mining. To evaluate feasibility of the suggested test framework, we selected a well-characterized assay that evaluates 'migration inhibition of neural crest cells.' Screening at the highest non-cytotoxic concentration resulted in 11 hits (e.g., geldanamycin, abiraterone, gefitinib, chlorpromazine, cyproconazole, arsenite). These were confirmed in concentration-response studies. Subsequent pharmacokinetic modeling indicated that triadimefon exerted its effects at concentrations relevant to the in vivo situation, and also interferon-ß and polybrominated diphenyl ether showed effects within the same order of magnitude of concentrations that may be reached in humans. In conclusion, the test battery framework can identify compounds that disturb processes relevant for human development and therefore may represent developmental toxicants. The open structure of the strategy allows rich information to be generated on both the underlying library, and on any contributing assay.
Subject(s)
Toxicity Tests/methods , Animals , Cell Differentiation/drug effects , Cell Movement/drug effects , Dose-Response Relationship, Drug , Embryonic Stem Cells/drug effects , HEK293 Cells/drug effects , Humans , Mice , Models, Theoretical , Neural Crest/cytologyABSTRACT
NADPH oxidases (NOX), catalyzing the reduction of molecular oxygen to form the superoxide radical anion (â¢O2â») and hydrogen peroxide (H2O2), are involved in several pathological conditions, such as stroke, diabetes, atherosclerosis, but also in chronic neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, or multiple sclerosis. GKT136901 is a novel NOX-1/4 inhibitor with potential application in the areas of diabetic nephropathy, stroke, or neurodegeneration. In the present study, we investigated additional pharmacological activities of the compound with respect to direct free radical scavenging. GKT136901 did not interact with nitric oxide (â¢NO), â¢O2â», or hydroxyl radicals (â¢OH), but it acted as selective scavenger of peroxynitrite (PON) already in the submicromolar concentration range. Alpha synuclein (ASYN) is a protein involved in the pathogenesis of Parkinson's disease and a known target for PON-dependent tyrosine nitration. Submicromolar concentrations of GKT136901 prevented tyrosine nitration and di-tyrosine-dependent dimer formation of ASYN by PON as indicated by Western blot and mass spectrometric analysis. GKT136901 itself was degraded when exposed to PON. In a human neuronal cell model, GKT136901 prevented both the depletion of reduced intracellular glutathione, and the degeneration of neurites when present during PON treatment of the cells. When GKT136901 was applied after PON treatment, no protective effect was observed, thus excluding an impact of GKT136901 on cellular death/survival pathways. In summary, selective scavenging of PON is an additional pharmacological property of the NOX-1/4 inhibitor GKT136901, and this may add to the efficiency of the drug in several disease models.
Subject(s)
Free Radical Scavengers/pharmacology , NADPH Oxidases/antagonists & inhibitors , Peroxynitrous Acid/metabolism , Pyrazoles/pharmacology , Pyridones/pharmacology , Amino Acid Sequence , Cell Line , Humans , Molecular Sequence Data , NADPH Oxidase 1 , NADPH Oxidase 4 , Neurodegenerative Diseases/metabolism , Nitric Oxide/metabolism , alpha-Synuclein/chemistry , alpha-Synuclein/metabolismABSTRACT
Inflammation is an important hallmark of all neurodegenerative diseases and activation of different glial populations may be involved in the progression of some of these disorders. Especially, the activation of astroglia can lead to long-term detrimental morphological changes, such as scar formation. Therefore, improved strategies to modulate inflammation in these cells are currently being investigated. We investigated the interaction of phosphodiesterase (PDE) 4 inhibitors, such as rolipram, with other agents raising cellular cAMP levels. When used alone, none of the PDE4 inhibitors increased cAMP levels. The adenylate cyclase activator forskolin, the ß(2)-adrenergic agonist clenbuterol and the mixed ß(1)/ß(2)-adrenergic agonist isoproterenol increased intracellular cAMP levels of cortical murine astrocytes. This increase was synergistically elevated by rolipram or the PDE4 inhibitor RO-201724, but not by inhibition of PDE3. Inflammatory stimulation of the cells with the cytokines TNF-α, IL-1ß and IFN-γ strongly induced PDE4B and augmented overall PDE4 activity, while PDE3 activity was low. Clenbuterol and forskolin caused downregulation of cytokines and chemokines such as IL-6 and MCP-1. This effect was further enhanced by rolipram, but not by the PDE3 inhibitor milrinone. The cAMP-raising drug combinations attenuated the upregulation of TNF-α and IL-6 mRNA and the secretion of IL-6, but did not affect initial NF-κB signalling triggered by the stimulating cytokines. These results indicate that PDE4 may be a valuable anti-inflammatory target in brain diseases, especially under conditions associated with stimulation of cAMP-augmenting astrocyte receptors as is observed by clenbuterol treatment.
Subject(s)
Adrenergic beta-Agonists/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Astrocytes/drug effects , Cyclic AMP/biosynthesis , Intracellular Fluid/drug effects , Phosphodiesterase 4 Inhibitors/pharmacology , Receptors, Adrenergic, beta-2/physiology , Up-Regulation/drug effects , Animals , Astrocytes/metabolism , Astrocytes/pathology , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Cerebral Cortex/pathology , Drug Therapy, Combination/methods , Female , Intracellular Fluid/metabolism , Mice , Mice, Inbred C57BL , Primary Cell Culture , Up-Regulation/physiologyABSTRACT
As neuronal differentiation of embryonic stem cells (ESCs) recapitulates embryonic neurogenesis, disturbances of this process may model developmental neurotoxicity (DNT). To identify the relevant steps of in vitro neurodevelopment, we implemented a differentiation protocol yielding neurons with desired electrophysiological properties. Results from focussed transcriptional profiling suggested that detection of non-cytotoxic developmental disturbances triggered by toxicants such as retinoic acid (RA) or cyclopamine was possible. Therefore, a broad transcriptional profile of the 20-day differentiation process was obtained. Cluster analysis of expression kinetics, and bioinformatic identification of overrepresented gene ontologies revealed waves of regulation relevant for DNT testing. We further explored the concept of superimposed waves as descriptor of ordered, but overlapping biological processes. The initial wave of transcripts indicated reorganization of chromatin and epigenetic changes. Then, a transient upregulation of genes involved in the formation and patterning of neuronal precursors followed. Simultaneously, a long wave of ongoing neuronal differentiation started. This was again superseded towards the end of the process by shorter waves of neuronal maturation that yielded information on specification, extracellular matrix formation, disease-associated genes and the generation of glia. Short exposure to lead during the final differentiation phase, disturbed neuronal maturation. Thus, the wave kinetics and the patterns of neuronal specification define the time windows and end points for examination of DNT.
Subject(s)
Cell Differentiation , Embryonic Stem Cells/cytology , Gene Expression Regulation, Developmental , Neurons/cytology , Neurons/metabolism , Toxicity Tests , Animals , Biomarkers/metabolism , Cell Cycle , Cell Line , Cell Lineage , Central Nervous System/cytology , Chromatin/metabolism , DNA/metabolism , Embryonic Stem Cells/metabolism , Mice , Multigene Family , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neuroglia/cytology , Neuroglia/metabolism , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription, GeneticABSTRACT
BACKGROUND AND PURPOSE: Glycogen synthase kinase-3 (GSK-3) affects neuropathological events associated with Alzheimers disease (AD) such as hyperphosphorylation of the protein, tau. GSK-3beta expression, enzyme activity and tau phosphorylated at AD-relevant epitopes are elevated in juvenile rodent brains. Here, we assess five GSK-3beta inhibitors and lithium in lowering phosphorylated tau (p-tau) and GSK-3beta enzyme activity levels in 12-day old postnatal rats. EXPERIMENTAL APPROACH: Brain levels of inhibitors following treatment in vivo were optimized based on pharmacokinetic data. At optimal doses, p-tau (Ser(396)) levels in brain tissue was measured by immunoblotting and correlated with GSK-3beta enzyme activities in the same tissues. Effects of GSK inhibitors on p-tau, GSK-3beta activities and cell death were measured in a human neuronal cell line (LUHMES). KEY RESULTS: Lithium and CHIR98014 reduced tau phosphorylation (Ser(396)) in the cortex and hippocampus of postnatal rats, while Alsterpaullone and SB216763 were effective only in hippocampus. AR-A014418 and Indirubin-3'-monoxime were ineffective in either brain region. Inhibition of p-tau in brain required several-fold higher levels of GSK inhibitors than the IC(50) values obtained in recombinant or cell-based GSK-3beta enzyme activity assays. The inhibitory effect on GSK-3beta activity ex vivo correlated with protection against cell death and decrease of p-tau- in LUHMES cells, using low microM inhibitor concentrations. CONCLUSIONS AND IMPLICATIONS: Selective small-molecule inhibitors of GSK-3 reduce tau phosphorylation in vivo. These findings corroborate earlier suggestions that GSK-3beta may be an attractive target for disease-modification in AD and related conditions where tau phosphorylation is believed to contribute to disease pathogenesis.
Subject(s)
Enzyme Inhibitors/pharmacology , Glycogen Synthase Kinase 3/antagonists & inhibitors , tau Proteins/metabolism , Aging/metabolism , Animals , Animals, Newborn , Blotting, Western , Brain/growth & development , Brain Chemistry/physiology , Cell Line , Female , Glycogen Synthase Kinase 3/metabolism , Humans , Immunohistochemistry , Immunoprecipitation , Indoles/pharmacology , Lithium Chloride/pharmacology , Maleimides/pharmacology , Neurons/drug effects , Neurons/metabolism , Phosphorylation , Rats , Rats, Wistar , Recombinant Proteins , Small Molecule Libraries , Thiazoles/pharmacology , Tissue Extracts/pharmacologyABSTRACT
One hemisphere of postnatal day 8 (P8) rats or P10 mice was irradiated with a single dose of 4-12 Gy, and animals were killed from 2 h to 8 weeks after irradiation (IR). In the subventricular zone (SVZ) and the granular cell layer (GCL) of the dentate gyrus, harboring neural and other progenitor cells, nitrosylation and p53 peaked 2-12 h after IR, followed by markers for active caspase-3, apoptosis-inducing factor and TUNEL (6-24 h). Ki67-positive (proliferating) cells had disappeared by 12 h and partly reappeared by 7 days post-IR. The SVZ and GCL areas decreased approximately 50% 7 days after IR. The development of white matter was hampered, resulting in 50-70% less myelin basic protein staining. Pretreatment with erythropoietin did not confer protection against IR. Caspase inhibition by overexpression of XIAP prevented caspase-9 and caspase-3 activation but not cell death, presumably because of increased caspase-independent cell death.
Subject(s)
Brain/embryology , Caspase Inhibitors , Enzyme Inhibitors/pharmacology , Erythropoietin/pharmacology , Stem Cells/pathology , Active Transport, Cell Nucleus , Animals , Apoptosis , Body Weight , Caspase 3 , Caspase 9 , Caspases/metabolism , Cell Death , Cell Proliferation , DNA Fragmentation , Dose-Response Relationship, Radiation , Enzyme Activation , Erythropoietin/metabolism , Hippocampus/metabolism , Immunohistochemistry , In Situ Nick-End Labeling , Ki-67 Antigen/biosynthesis , Mice , Mice, Inbred C57BL , Myelin Basic Protein/metabolism , Proteins/metabolism , Rats , Rats, Wistar , Time Factors , Tumor Suppressor Protein p53/metabolism , X-Linked Inhibitor of Apoptosis ProteinABSTRACT
In pathological situations, different modes of cell death are observed, and information on the role and uptake of nonapoptotic corpses is scarce. Here, we modeled two distinct forms of death in human Jurkat T cells treated with staurosporine: classical apoptosis under normal culture conditions and programmed death with necrotic morphology under ATP-depleting conditions (necPCD). When offered to phagocytes, both types of cell corpses (but not heat-killed unscheduled necrotic cells) reduced the release of the proinflammatory cytokine TNF from the macrophages. The necPCD cells were efficiently engulfed by macrophages and microglia, and from mixtures of necPCD and apoptotic cells macrophages preferentially engulfed the necrotic cells. Using a newly developed assay, we demonstrated that phosphatidylserine is translocated to the surface of such necrotic cells. We demonstrate that this can occur independently of calcium signals, and that surface phosphatidylserine is essential for the uptake of necrotic cells by both human macrophages and murine microglia.
Subject(s)
Inflammation/metabolism , Phagocytosis/physiology , Phosphatidylserines/physiology , Animals , Annexin A5/pharmacology , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Apoptosis/physiology , CD36 Antigens/immunology , Calcium/pharmacology , Calcium/physiology , Cell Line , Cell Membrane/chemistry , Cells, Cultured , Escherichia coli/immunology , Formaldehyde/pharmacology , Humans , Inflammation/immunology , Ionomycin/pharmacology , Jumonji Domain-Containing Histone Demethylases , Jurkat Cells/pathology , Lipopolysaccharide Receptors/immunology , Liposomes/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Membrane Lipids/analysis , Membrane Lipids/physiology , Mice , Microglia/cytology , Microglia/drug effects , Microglia/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Necrosis , Oligomycins/pharmacology , Oligopeptides/pharmacology , Phagocytosis/immunology , Phosphatidylserines/analysis , Polymers/pharmacology , Receptors, Cell Surface/antagonists & inhibitors , Staurosporine/pharmacology , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The solidification/stabilization of sodium arsenite, sodium arsenate, arsenic trioxide and arsenic pentoxide at dosages of approximately 10% has been investigated using sequential batch leaching tests. The leaching of arsenic, which was found to be diffusion based, was clearly least effective for those formulations containing additional iron(II). Calcium was found to influence the leaching of cement immobilized arsenic: those formulations containing the greatest Ca:As mole ratios were generally the most successful. Analysis using both FTIR and SEM revealed substantial changes to the cement matrices of those formulations to which the ferrous sulfate had been added. Ettringite was identified in the cement+ferrous sulfate formulations.
Subject(s)
Arsenic/chemistry , Carcinogens/chemistry , Refuse Disposal , Arsenic/analysis , Calcium/chemistry , Carcinogens/analysis , Conservation of Natural Resources , Construction Materials , Diffusion , Environmental Pollution/prevention & control , Microscopy, Electron, Scanning , Spectroscopy, Fourier Transform InfraredABSTRACT
Increased brain ganglioside levels are a hallmark of various neuroinflammatory pathologies. Here, we provide evidence that murine microglia can secrete disialoganglioside GD3 upon exposure to inflammatory stimuli. Comparison of different neural cell types revealed a particular and specific sensitivity of oligodendrocytes towards exogenous GD3. Oligodendrocyte death triggered by GD3 was preceded by degeneration of cellular processes, and associated with typical features of apoptosis, such as chromatin condensation, exposure of phosphatidylserine, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential, followed by the loss of plasma membrane integrity and detachment of disintegrated oligodendrocytes. Overexpression of bcl-2 partially protected oligodendrocytes from death. In contrast, treatment with the pan-caspase inhibitor zVAD-fmk did not prevent phosphatidylserine exposure, chromatin margination at the nuclear periphery, and death, although caspase-3 was blocked. Thus, GD3 produced by microglia under neuroinflammatory conditions may function as a novel mediator triggering mitochondria-mediated, but caspase-independent, apoptosis-like death of oligodendrocytes.
Subject(s)
Apoptosis , Gangliosides/metabolism , Microglia/metabolism , Oligodendroglia/cytology , Animals , Caspase Inhibitors , Cell Differentiation , Cell Nucleus/metabolism , Cell Survival , Cells, Cultured , Humans , Mice , Mice, Inbred BALB C , Mitochondria/metabolism , Phosphatidylserines/metabolismABSTRACT
The pathogenesis of some neurodegenerative disorders has been linked to excitotoxicity, excess generation of nitric oxide (NO) and apoptosis. Here, we used a model of NO-triggered neuronal apoptosis that was strictly dependent on autocrine NMDA receptor (NMDA-R) activation and intracellular Ca2+ increase. We investigated the efficiency and potentially beneficial effects of calpain inhibition. Three calpain inhibitors that prevented intracellular fodrin proteolysis also blocked apoptotic features such as decrease in mitochondrial membrane potential, chromatin breakdown, and subsequent death of cerebellar granule neurons exposed to NO donors (S-nitroso-L-glutathione, S-nitroso-N-acetyl-d,l-penicillamine, and diethylamino-diazenolate-2-oxide). Since inhibitors did not interfere with NMDA-R activation, we suggest that block of calpains blunts NO-triggered neuronal apoptosis by stopping the cascade downstream of primary autocrine excitotoxic events.